Legislative, Regulatory & Legal

Horizon Pharma will be forced to lower the price on its life-saving Procysbi medication, after the Patented Medicines Prices Review Board (PMPRB) decided the $300,000-a-year drug was too expensive. 

The changes, which are an update to the National Drug Schedules, affect concentrations up to and including 0.025%. 

The $750 million is to be used for recruitment and retention programs, rural and remote programming and expanding capacity across the system.

The move has been met with fierce opposition from some animal rescuers and advocates.

The cabinet order maintaining COVID-19 border measures will not be renewed when it expires on Sept. 30.

In what the Ontario college's discipline tribunal called a 'grooming tactic,' Dr. Jamal Aboujamra tried to find out what the patient's mother knew 'to gauge from her reaction whether it was safe' to sexually abuse the patient.

Liberal ministers confirmed they were discussing whether to continue the mandatory use of the ArriveCan app.

Soldier says: ‘It was wrong for me to present myself as a Canadian Armed Forces member to publicly express my private views.’